3,4-methylenedioxyamphetamine (MDA) self-administration and neurotoxicity
- 31 July 1991
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 39 (3) , 569-574
- https://doi.org/10.1016/0091-3057(91)90129-p
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analoguesPharmacology Biochemistry and Behavior, 1989
- Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in ratsLife Sciences, 1989
- Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbensPharmacology Biochemistry and Behavior, 1989
- The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brainEuropean Journal of Pharmacology, 1986
- Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve TerminalsScience, 1985
- Differential effects of phencyclidine and MDA on complex operant behavior in monkeysPharmacology Biochemistry and Behavior, 1984
- Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetaminePharmacology Biochemistry and Behavior, 1984
- The effects of putative 5-hydroxytryptamine receptor active agents ond-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesionBrain Research, 1984
- Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neuronsPharmacology Biochemistry and Behavior, 1980
- Self-administration of psychomotor stimulant drugs: The effects of unlimited accessPharmacology Biochemistry and Behavior, 1976